Check out NPF's past Skin of Color webinar (February 2022): 

Psoriasis and Skin of Color: Prevalence, Clinical Features, and Challenges That Impact Diagnosis & Management presented by Dr. Tiffany Mayo

OBJECTIVES

• Understanding appropriate diagnosis of psoriatic disease in the skin of color and underserved from a cross-disciplinary perspective
• Outlining the safety, efficacy, and role of current and emerging treatments in addressing both skin and joint symptoms for psoriasis and psoriatic arthritis
• Addressing comorbid conditions in diverse populations and in specific regions of the United States
• Applying patient-centric, collaborative care and appropriate shared management model for the treatment of psoriatic disease in patients

PRESENTATIONS AND SPEAKERS

• Eingun James Song, MD, FAAD - Director of Clinical Research, Frontier Dermatology Partners
• Hear from Eingun James Song, M.D., FAAD about understanding an appropriate diagnosis of psoriatic disease in the skin of color and underserved populations from a cross-disciplinary perspective, including current and emerging treatments, and addressing comorbid conditions in diverse populations and specific regions in the U.S. Register and submit questions for the Q&A panel.

AVAILABLE CREDITS/POINTS

• The National Psoriasis Foundation designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• The National Psoriasis Foundation designates this live activity for a maximum of 1 Hour(s) of Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE STATEMENTS

Event Disclosures

• Any relevant financial relationships have been mitigated.

Commercial Support

• This program is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $351,404, with 2 percent funded by CDC/HHS and $14.3 million amount and 98 percentage funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

ACCREDITATION STATEMENT

• The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

For more information please visit the official event page.